Poor tumour characteristics were observed in the aggressive ILC subtypes, including larger tumour size, younger patient age, LN metastasis, higher proliferative activity, and more frequent ER negativity and HER2 positivity. This evidence concerns the gene ERBB2 and neoplasm.